Design and rationale of the Danish trial of beta-blocker treatment after myocardial infarction without reduced ejection fraction: study protocol for a randomized controlled trial

BACKGROUND: Treatment with beta-blockers is currently recommended after myocardial infarction (MI). The evidence relies on trials conducted decades ago before implementation of revascularization and contemporary medical therapy or in trials enrolling patients with heart failure or reduced left ventr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristensen, Anna Meta Dyrvig, Bovin, Ann, Zwisler, Ann Dorthe, Cerquira, Charlotte, Torp-Pedersen, Christian, Bøtker, Hans Erik, Gustafsson, Ida, Veien, Karsten Tange, Thomsen, Kristian Korsgaard, Olsen, Michael Hecht, Larsen, Mogens Lytken, Nielsen, Olav Wendelboe, Hildebrandt, Per, Foghmar, Sussie, Jensen, Svend Eggert, Lange, Theis, Sehested, Thomas, Jernberg, Tomas, Atar, Dan, Ibanez, Borja, Prescott, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245032/
https://www.ncbi.nlm.nih.gov/pubmed/32446298
http://dx.doi.org/10.1186/s13063-020-4214-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245032/
https://www.ncbi.nlm.nih.gov/pubmed/32446298
http://dx.doi.org/10.1186/s13063-020-4214-6

Ejemplares similares